证券代码：002414 证券简称：高德红外 公告编号：2025-038 4、会议召开的日期、时间： （1）现场会议召开时间：2025 年 12 月 22 日（星期一）下午 14:30 （2）网络投票时间：2025 年 12 月 22 日 武汉高德红外股份有限公司 关于召开 2025 年第二次临时股东大会的通知 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 武汉高德红外股份有限公司（以下简称"公司"）将于 2025 年 12 月 22 日 召开 2025 年第二次临时股东大会，现将此次会议的具体事项通知如下： 一、召开会议的基本情况 1、股东大会届次：2025年第二次临时股东大会。 2、会议召集人：公司董事会。 3、会议召开的合法、合规性：本次股东大会会议召开符合《中华人民共和 国公司法》《深圳证券交易所股票上市规则》等有关法律、规范性文件及《公司 章程》的规定。 其中，通过深圳证券交易所交易系统进行网络投票的具体时间为：2025 年 12 月 22 日上午 9:15—9:25，9:30—11:30，下午 13:00—15:00；通过深圳证券 交易所互联网投票 ...

Summary of Gaode Infrared Conference Call Company Overview - Gaode Infrared is one of the few private enterprises in China with complete equipment integration qualifications, covering both civilian temperature measurement devices and military equipment pods. The company has established a presence in five major weapon systems, including anti-tank missiles and air-to-air missiles. By 2025, the revenue from equipment integration is expected to exceed 50% for the first time [2][3][8]. Financial Performance - After facing pressure during the "14th Five-Year Plan" period, Gaode Infrared's profitability is expected to gradually recover starting in 2024. The company anticipates achieving record-high revenue in 2025, with a significant year-on-year increase in net profit attributable to the parent company. Both gross and net profit margins are projected to return to high levels [2][4][5]. - As of the end of Q3 this year, the company's contract liabilities approached 1.3 billion yuan, significantly higher than the previous level of 500-600 million yuan, indicating strong downstream demand [5]. Business Segments and Core Technologies - Gaode Infrared's business is divided into four main segments: infrared chips, complete machine products, equipment integration, and new types of ammunition. The core technology of infrared chips is widely used in precision-guided systems in aerospace [3][6]. - The company has established deep collaborations with automotive manufacturers such as Dongfeng and GAC, with civilian business expected to grow by over 30% in 2025, reaching over 2 billion yuan in revenue [2][6]. Market Expansion - In the domestic market, Gaode Infrared has frequently announced contracts and orders since 2021, transitioning from primarily chip orders to complete equipment system orders. The company showcased its optical systems during the 93rd anniversary parade [7]. - Internationally, the company announced complete equipment system orders valued at over 300 million yuan in March 2024 and nearly 700 million yuan in July 2025. These low-cost precision-guided products are particularly favored by countries in the Middle East and Africa, aiding further international market expansion [7]. Future Outlook - Gaode Infrared possesses unique advantages as the only private entity with complete equipment integration qualifications, enhancing its competitiveness. The integrated expansion from chips to complete weapon systems has increased the value and level of its offerings. The shift from domestic to international markets further broadens the company's growth potential, especially in the low-cost segment, where it has a clear advantage over state-owned enterprises. Therefore, the future development prospects for Gaode Infrared are very optimistic [8].

Core Viewpoint - Wuhan's economy is showing strong recovery post-COVID-19, with significant growth in GDP and major investments planned for the future [1][5][9]. Economic Performance - In 2020, Wuhan's GDP reached 1.56 trillion yuan, ranking ninth among cities in China, despite a 40.5% decline in the first quarter due to the pandemic [1][5]. - For 2021, Wuhan has set a 10% economic growth target, with early indicators suggesting a potential growth of over 50% in the first quarter [1][5]. Investment and Business Activities - Wuhan hosted significant events in April 2021, including the Yabuli China Entrepreneurs Forum and the World Health Expo, attracting numerous entrepreneurs and businesses [2][5]. - The city initiated a "cloud investment" event on the first day of its reopening, resulting in the signing of 69 projects worth a total of 245.1 billion yuan [2][3]. Local Company Performance - As of April 2021, 32 out of 58 listed companies in Wuhan reported a year-on-year increase in net profit, with 9 companies showing growth exceeding 100% [6][7]. - Mingde Biological, a company focused on rapid diagnostic equipment, projected a net profit increase of 959.58% to 1104.07% for 2020, driven by sales of nucleic acid testing products [7][8]. Future Development Plans - Wuhan aims to develop its health industry significantly, with expectations for the sector to reach a trillion yuan scale in the next five years [9]. - The city plans to enhance its status as a national technology innovation center, focusing on high-end innovation platforms and talent development [9][10]. - The government emphasizes the importance of Wuhan as a regional economic engine, aiming to strengthen its role in driving the development of the surrounding areas [10].

Group 1 - Kanglongda's shareholder plans to reduce holdings by up to 3% of the company's shares, totaling no more than 4.83 million shares [1] - The company specializes in the research, production, and sales of special and ordinary labor protection gloves [1] Group 2 - Haizheng Pharmaceutical's subsidiary plans to collaborate with East China Institute on a biological method for synthesizing heparin, with a project contract amount not exceeding 120 million yuan [2] - The company focuses on the research, production, and sales of chemical raw materials and formulations [3] Group 3 - Tianyin Holdings received approval from the China Securities Regulatory Commission for a stock issuance to specific investors [4] - The company is engaged in the sales of smart terminals, e-commerce, lottery, mobile resale, and mobile internet businesses [4] Group 4 - Shanghai Yashi plans to use up to 200 million yuan of temporarily idle raised funds for cash management in high-security, liquid deposit products [5] - The company specializes in supply chain logistics and execution trade [6] Group 5 - Parker New Materials intends to use 130 million yuan of idle raised funds to purchase structured deposits with expected annual yields between 0.59% and 2.9001% [7] - The company focuses on the research, production, and sales of various types of ring forgings, free forgings, and die forgings [7] Group 6 - Huayang New Materials appointed Jing Hongsheng as the new general manager [8] Group 7 - Liyuan Technology's shareholder plans to reduce holdings by up to 2.03% of the company's shares, totaling no more than 3.04 million shares [9] - The company specializes in the research, design, and integration of environmental water treatment systems and hydrogen fuel cell engine systems [9] Group 8 - Shengnuo Biopharmaceutical's subsidiary received approval for the listing application of Visepegenatide raw materials, a GLP-1 receptor agonist for treating type 2 diabetes and obesity [10][11] - The company focuses on the research, production, and sales of peptide raw materials and formulations [10] Group 9 - Puluo Pharmaceutical plans to repurchase shares worth between 180 million and 360 million yuan, with a maximum price of 23 yuan per share [12] - The company specializes in the research, production, and sales of raw material intermediates and innovative drugs [12] Group 10 - Dongfang Electric's subsidiary plans to establish a joint venture with Anhui Waneng Energy, with a registered capital of approximately 1.857 billion yuan [13] - The company is involved in the development, design, manufacturing, and sales of advanced power generation equipment [13] Group 11 - Hefei China announced that its stock will resume trading on November 20 after completing a review of abnormal trading fluctuations [14] - The company focuses on international trade and after-sales services related to in vitro diagnostic medical devices [14] Group 12 - Dafeng Industrial won a bid for the stage equipment project of the Shenzhen International Performing Arts Center, with a contract amount of 165 million yuan [15] - The company specializes in cultural sports equipment, digital art technology, and operation services [15] Group 13 - Baiyunshan's subsidiary received a drug registration certificate for An Gong Niu Huang Wan in Vietnam [16] - The company is engaged in the research, manufacturing, and sales of traditional Chinese and Western medicines [16] Group 14 - Neusoft Group received a notification to supply intelligent cockpit domain controllers for multiple models from a well-known domestic automobile manufacturer, with an estimated total amount of about 4.2 billion yuan [17] - The company focuses on providing industry solutions and software products [17] Group 15 - Huayu Pharmaceutical's product received overseas marketing approval [18] - The company specializes in the research, production, and sales of innovative and high-quality generic drugs in the oncology field [18] Group 16 - Yao Pi Glass received approval from the CSRC for its stock issuance to specific investors [19] - The company specializes in the production and sales of float glass and processed glass [19] Group 17 - Guangyu Yuan's vice president Wang Junbo resigned due to work adjustments [20] - The company focuses on the production and sales of traditional Chinese medicine products [20] Group 18 - Biyi Co. received approval from the CSRC for its stock issuance to specific investors [21] - The company specializes in the design, manufacturing, and sales of smart small household appliances [21] Group 19 - Sunshine Nuohe's application for acquiring 100% equity of Jiangsu Langyan Life Science Technology Co., Ltd. through share issuance and convertible bonds has been accepted by the Shanghai Stock Exchange [22] - The company provides comprehensive drug research and development services for domestic pharmaceutical enterprises and research institutions [22] Group 20 - Longxin General plans to increase capital in its wholly-owned subsidiary by no more than 1.65 billion yuan [23] - The company specializes in the research, production, and sales of motorcycles and engines [23] Group 21 - Jiekang Equipment received a corrective order from the Tianjin Securities Regulatory Bureau due to internal control deficiencies [24] - The company specializes in the research, production, and sales of nuclear biochemical safety equipment [24] Group 22 - Wantong Technology plans to raise no more than 920 million yuan through a private placement to supplement working capital [25] - The company focuses on information technology services for highways and ports [25] Group 23 - Dongshan Precision has submitted an application for H-share listing to the Hong Kong Stock Exchange [26] - The company specializes in the research, production, and sales of electronic circuit products and precision components [26] Group 24 - Yonghe Intelligent Control plans to publicly transfer 100% equity of its wholly-owned subsidiary Kunming Medical Oncology Hospital [27] - The company specializes in water and heating valve fittings, tumor precision radiation therapy, and photovoltaic battery businesses [27] Group 25 - Aok Shares signed a strategic cooperation framework agreement with Suzhou Qitian New Materials Co., Ltd. [28] - The company focuses on the research and production of high-end new materials derived from ethylene oxide and ethylene [28] Group 26 - Hongquan Technology's shareholder plans to reduce holdings by up to 3% of the company's shares, totaling no more than 299,440 shares [29] - The company specializes in the research, production, and sales of intelligent connected products and software platform development [29] Group 27 - Shilong Industrial's controlling shareholder plans to reduce holdings by up to 3% of the company's shares, totaling no more than 7.2 million shares [30] - The company specializes in the research, production, and sales of chemical products [30] Group 28 - Tangrenshen decided to terminate the investment in the "Dongchong Phase III Pig Breeding Base Construction Project," reallocating the remaining funds of 78.9587 million yuan to supplement working capital [31] - The company specializes in the research, production, and sales of feed, pigs, meat products, and animal health products [31] Group 29 - Gaode Infrared's actual controller plans to reduce holdings by up to 3% of the company's shares, totaling no more than 12.8 million shares [32] - The company specializes in infrared focal plane detector chips and infrared thermal imaging systems [32] Group 30 - Kangyuan Pharmaceutical's actual controller recently increased holdings by 20,000 shares [33] - The company specializes in the research, production, and sales of pharmaceuticals [33] Group 31 - Haida Group plans to repurchase shares worth between 1 billion and 1.6 billion yuan, with a maximum price of 62.00 yuan per share [34] - The company provides overall solutions for animal husbandry [34] Group 32 - Qizhong Technology's 850 million yuan convertible bonds have been approved for listing [35] - The company specializes in advanced packaging and testing of integrated circuits [35] Group 33 - Dingyang Technology launched the new SNA5000B series vector network analyzer [36] - The company specializes in the research, production, and sales of general electronic testing and measuring instruments [36] Group 34 - Airo Energy plans to distribute a cash dividend of 0.9375 yuan per share to all shareholders [37] - The company specializes in photovoltaic energy storage systems and products [37] Group 35 - Hechuan Technology's actual controller and some directors plan to reduce holdings by up to 6% of the company's shares [38] - The company specializes in the research, production, and sales of industrial automation products [38] Group 36 - China First Heavy Industries' chairman was arrested for suspected bribery [39] - The company specializes in heavy machinery manufacturing for various industries [39] Group 37 - Lianhuan Pharmaceutical plans to invest 15 million yuan in joint research with Nanjing University for anti-thrombotic small nucleic acid drugs [40] - The company specializes in the manufacturing and sales of chemical raw materials [40] Group 38 - Anxu Biotech's shareholder plans to reduce holdings by up to 0.94% of the company's shares, totaling no more than 120,000 shares [41] - The company specializes in the research, production, and sales of POCT reagents and instruments [41] Group 39 - Yaxiang Integration's shareholder reduced holdings by 130,000 shares [42] - The company specializes in providing cleanroom engineering and related services for high-tech electronic industries [42] Group 40 - Zhongwen Media plans to use up to 9.5 billion yuan of idle funds to purchase financial products [43] - The company specializes in traditional publishing and various new media businesses [43]

Core Viewpoint - Gaode Infrared (002414.SZ) experienced a significant drop in stock price, reaching a new low since October 24, with a decline of 6.2% to 11.8 yuan, bringing its market capitalization close to 50 billion yuan [1] Company Summary - The actual controller and chairman, Huang Li, plans to reduce his holdings by up to 128 million shares, accounting for 3% of the total shares, within three months after a 15-trading-day period from the announcement [1] - The reason for the share reduction is to meet funding needs for the development of other innovative industries outside the listed company [1]

Core Viewpoint - The actual controller and chairman of Gaode Infrared, Huang Li, plans to reduce his shareholding due to funding needs for another listed company, with a maximum reduction of 128,122,083 shares, accounting for 3.00% of the total share capital [1][2]. Shareholding Reduction Plan - Huang Li currently holds 1,157,349,375 shares, representing 27.10% of the total share capital [1]. - The planned reduction will occur within three months after the announcement, excluding the trading window, through centralized bidding and block trading [1]. - The maximum shares to be reduced through centralized bidding is 42,707,361 shares (1.00% of total share capital), while block trading will account for up to 85,414,722 shares (2.00% of total share capital) [1]. Financial Implications - Based on the closing price of 12.58 yuan on November 18, the cash amount Huang Li could realize from the share reduction is approximately 1.612 billion yuan [1]. - The company has previously raised approximately 2.5 billion yuan through a non-public offering of 84,260,195 shares at a price of 29.67 yuan per share, with a net amount received of about 2.477 billion yuan after deducting underwriting fees [2].

Group 1 - The actual controller and chairman of Gaode Infrared, Huang Li, plans to reduce his shareholding by up to 128,122,083 shares, accounting for no more than 3.00% of the company's total share capital, due to funding needs for other innovative industries [2] - Gaode Infrared's main business includes infrared focal plane detector chips, infrared thermal imaging systems, and traditional non-lethal ammunition, among others [2] - For the first three quarters of 2025, Gaode Infrared achieved a revenue of 3.068 billion yuan, representing a year-on-year growth of 69.27%, and a net profit attributable to shareholders of 582 million yuan [2] Group 2 - Puzhou Technology, established in 2015, is a high-tech company based in Wuhan, specializing in the research, production, sales, operation, and low-altitude data operation of drones [3] - Zhonghua Brain Machine, also based in Wuhan, focuses on the development of a hardware and software platform for brain-computer interface systems, with a complete research and production system [3] - Recently, Zhonghua Brain Machine announced the successful completion of the first clinical implantation of a domestically developed brain-computer interface chip in collaboration with Huazhong University of Science and Technology [3]

Core Viewpoint - The actual controller and chairman of Wuhan Gaode Infrared Co., Ltd., Huang Li, plans to reduce his shareholding by up to 128,122,083 shares, representing no more than 3.00% of the company's total share capital, to fund the development of other innovative industries outside the company [1][2][5]. Group 1: Share Reduction Plan - The reason for the share reduction is to support the business development needs of other innovative industries invested by the actual controller [1][2]. - The shares to be reduced will be sourced from those acquired before the company's initial public offering, including shares from capital reserve transfers [2]. - The reduction will occur through centralized bidding and block trading, with a maximum of 42,707,361 shares (1.00% of total shares) through centralized bidding and 85,414,722 shares (2.00% of total shares) through block trading [2][3]. Group 2: Commitment and Compliance - Huang Li has made commitments regarding share transfer restrictions, including a 36-month lock-up period post-IPO and a limit on annual transfers during his tenure [4]. - The current share reduction plan aligns with previously disclosed intentions and commitments, and there are no circumstances that would prevent the reduction under relevant regulations [5]. - As of the announcement date, Huang Li and his concerted actions hold a total of 2,711,547,739 shares, accounting for 63.49% of the company's total share capital, ensuring that the reduction will not affect the company's control or governance structure [5][6].

Core Insights - On November 18, several companies disclosed their shareholding changes, with 康缘药业, 超达装备, and 海大集团 announcing share buybacks, while 15 companies, including 立达信 and 艾布鲁, reported share reductions [1][2]. Group 1: Share Buybacks - 康缘药业's actual controller and director, 肖伟, increased his shareholding by 20,000 shares [2]. - 超达装备 secured a stock repurchase loan commitment from China Bank for up to 450 million yuan [2]. - 海大集团 plans to repurchase shares worth no less than 1 billion yuan and up to 1.6 billion yuan [2]. Group 2: Share Reductions - 立达信's shareholder, 李春华, intends to reduce his stake by no more than 1.56% [2]. - 艾布鲁's controlling shareholder, 钟儒波, plans to reduce his stake by no more than 3% [2]. - 高德红外's actual controller, 黄立, aims to reduce his stake by no more than 3% [2]. - 嘉美包装's shareholders plan to collectively reduce their stake by no more than 1.16% [2]. - 蓄奥规划's shareholders intend to reduce their stake by no more than 1% [2]. - 君逸数码's shareholder, 成都高创投, plans to reduce his stake by no more than 1% [2]. - 联合水务's shareholder, 上海衡联, intends to reduce his stake by no more than 0.14% [2]. - 亚翔集成's second-largest shareholder has reduced 130,000 shares and is still in the reduction period [2]. - 芯朋微's controlling shareholder, 张立新, has terminated his reduction plan early [2]. - 安旭生物's shareholder, 马华祥, plans to reduce his stake by no more than 0.94% [2]. - 农心科技's shareholder, 宁波农旗, intends to reduce his stake by no more than 0.54% [2]. - 禾川科技's actual controller and others plan to reduce their stake by no more than 6% [2]. - 世龙实业's shareholder, 电化高科, plans to reduce his stake by no more than 3% [2]. - 中国化学's executive, 聂宁新, intends to reduce his stake by no more than 60,000 shares [2]. - 鸿泉技术's shareholder, 千方科技, plans to reduce his stake by no more than 3% [2].

Core Viewpoint - The actual controller and chairman of Gaode Infrared, Huang Li, plans to reduce his shareholding by up to 128 million shares, accounting for 3.00% of the total share capital, to fund the business development of another listed company [1][2]. Group 1: Shareholding and Reduction Plan - Huang Li directly holds 27.10% of Gaode Infrared's shares, while he and his concerted parties collectively hold 63.49% [2]. - The reduction plan will not lead to a change in the company's control or affect its governance structure and ongoing operations [2]. Group 2: Company Background - Gaode Infrared, founded in 1999, specializes in the research and production of infrared core chips, infrared thermal imaging products, high-end optoelectronic systems, and advanced equipment systems [2]. Group 3: Financial Performance - Gaode Infrared's net profit has declined for three consecutive years, with projected net profits of 502 million yuan, 67.7 million yuan, and a loss of 447 million yuan for 2022, 2023, and 2024 respectively, representing year-on-year declines of 54.82%, 86.51%, and 760.56% [2]. - The company has seen significant growth in revenue this year, with a 69.27% year-on-year increase to 3.068 billion yuan in the first three quarters, and a net profit increase of 1058.95% to 582 million yuan [2].